A computational study shows that dozens of mutations help the virus’ spike protein evade antibodies…
Browsing: Antibodies
Antibodies are specialized proteins produced by the immune system to recognize and neutralize foreign substances like viruses, bacteria, and toxins. Central to immunology and medical research, antibodies play a critical role in vaccine development, diagnostics, and targeted therapies for diseases such as cancer and autoimmune disorders. Scientists continually study how antibodies are generated, how they evolve to combat emerging pathogens, and how they can be engineered for advanced treatments. Stay updated with the latest research on antibody structure, function, and innovative applications in medicine and biotechnology.
People vaccinated three times or vaccinated after an earlier COVID-19 infection had comparable neutralizing antibody…
Researchers discovered P36-5D2, an antibody effective against major SARS-CoV-2 variants. It showed significant prophylactic effects…
Omicron, emerging swiftly as a dominant variant, is less susceptible to both monoclonal antibodies and…
Research from the University of Massachusetts Amherst reveals that vaccinated breastfeeding women pass COVID-19 antibodies…
Cedars-Sinai Investigators Found Evidence of an Overactive Immune Response SARS-CoV-2 infection can induce an extended…
Penn State researchers have uncovered a new mechanism of viral neutralization where antibodies distort the…
The findings could lead to the development of more effective vaccines and antibody treatments for…
New Study Adds More Evidence for Omicron Immune Evasion Results suggest that previously infected individuals…
Recovered COVID-19 patients who later got vaccinated developed antibodies with superior potency against variants, suggesting…
COVID-19 infection plus vaccination produces the strongest, broadest protection. Antibodies against the SARS-CoV-2 spike protein…
New study models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed…
Vaccines are effective in decreasing hospitalization and deaths from COVID-19 infection but the emergence of…
COVID-19’s lingering effects may stem from antibodies that mimic the virus itself, binding ACE2 receptors…
Vaccination boosts antibody levels beyond natural infection, enhancing cross-variant protection, especially against Delta. With the…
The antibodies’ ability to neutralize COVID-19 did not differ significantly over the six-month period. A…
Japanese researchers created a mouse vaccine that shifts the immune response to the conserved core…
Engineered antibodies combining IgM and IgG traits boost immune attacks on blood cancer cells. Researchers…